DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Kim JB, Lee M, Park SY. et al.
Sorafenib inhibits cancer side population cells by targeting c‑Jun N‑terminal kinase signaling.

Mol Med Rep 2015;
12 (06) 8247-8252

Download Bibliographical Data

Access:
Access: